0.9021
1.25%
0.0111
After Hours:
.86
-0.0421
-4.67%
60 Degrees Pharmaceuticals Inc stock is traded at $0.9021, with a volume of 63,606.
It is up +1.25% in the last 24 hours and down -13.26% over the past month.
60 Degrees Pharmaceuticals Inc operates as a specialty pharmaceutical company with the goal of using biological science and applied research to develop and commercialize new therapies for the prevention and treatment of infectious diseases. The firm's pipeline products under development cover development programs for COVID-19, fungal, tick-borne, and other viral diseases.
See More
Previous Close:
$0.891
Open:
$0.88
24h Volume:
63,606
Relative Volume:
0.17
Market Cap:
$1.69M
Revenue:
$90,700
Net Income/Loss:
$-3.43M
P/E Ratio:
-0.5546
EPS:
-1.6266
Net Cash Flow:
$-4.65M
1W Performance:
+24.94%
1M Performance:
-13.26%
6M Performance:
-64.20%
1Y Performance:
-88.61%
60 Degrees Pharmaceuticals Inc Stock (SXTP) Company Profile
Name
60 Degrees Pharmaceuticals Inc
Sector
Industry
Phone
202-327-5422
Address
1025 CONNECTICUT AVENUE NW, WASHINGTON
60 Degrees Pharmaceuticals Inc Stock (SXTP) Latest News
TNF Pharmaceuticals (NASDAQ:TNFA) Stock Quotes, Forecast and News Summary - Benzinga
SEC Form DEF 14A filed by 60 Degrees Pharmaceuticals Inc. - Quantisnow
Allovir (ALVR) Stock Experiences Significant Decline Amid Negati - GuruFocus.com
Why Is Infection Treatment Focused-60 Degrees Pharmaceuticals Stock Soaring Today? - MSN
SXTP stock plunges to 52-week low, touches $1 mark By Investing.com - Investing.com UK
Why Are 60 Degrees Pharmaceuticals Shares Up By 50% Today? - MSN
60 Degrees Pharmaceuticals Outlines Plans For Rare Tick-Borne Infection Trial Evaluating Its Malaria Drug - MSN
60 Degrees Pharmaceuticals launches Arakoda promotional pilot - TipRanks
60 Degrees Pharmaceuticals pilots ARAKODA awareness program By Investing.com - Investing.com South Africa
60 Degrees Pharmaceuticals pilots ARAKODA awareness program - Investing.com
SXTP stock plunges to 52-week low, touches 1.01 USD By Investing.com - Investing.com Canada
60 Degrees Pharmaceuticals Inc. Announces ARAKODA® Promotional Pilot in Advance of Expanded U.S. Launch - The Manila Times
Del Taco Leads the Value Pack with New Del's Mucho Meal$™ and the Return of Cookie Butter Shake! - The Manila Times
Form PRE 14A 60 DEGREES PHARMACEUTICA For: Oct 02 - StreetInsider.com
K-pop group Fifty Fifty off to strong start with member line-up reboot - The Straits Times
Documented Gang Member Sentenced to Life in Prison for Killing Five People - Harris County District Attorney's Office
Ultraviolette set to export F77 sports bikes to European countries - Business Upturn
Tectonic Therapeutic reports findings from Phase Ia trial of TX45 - Clinical Trials Arena
Tectonic Therapeutic Announces Favorable Phase 1a Safety, Tolerability and PK/PD Results for Lead Program TX45 - EIN News
Market Trading Guide: Century Textiles, Jubilant Foodworks among 5 stock recommendations for Friday - The Economic Times
Heavy Buying Alert: Multibagger IT-stock Hits Upper Circuits On September 18; Zooms 69 Per Cent From 52-Week Low! - Dalal Street Investment Journal
100 films to be made in 48 hours - IOL
60 Degrees Pharmaceuticals (NASDAQ:SXTP) Rating Reiterated by HC Wainwright - Defense World
Hyliion Holdings And 2 Other Stocks Under $5 Executives Are Buying - Benzinga
60 degrees pharmaceuticals director buys $8,500 in stock By Investing.com - Investing.com Canada
60 degrees pharmaceuticals director buys $8,500 in stock - Investing.com India
60 Degrees Pharmaceuticals (NASDAQ:SXTP) Trading Down 3.1% - Defense World
SXTPW60 Degrees Pharmaceuticals, Inc. Warrant Latest Stock News & Market Updates - StockTitan
60 Degrees Pharmaceuticals Announces Closing of $4 Million Private Placement - citybiz
60 Degrees Pharmaceuticals, Inc. Announces Closing of $4 - GlobeNewswire
60 Degrees Pharmaceuticals, Inc. Announces Closing of $4 Million Private Placement Priced At-the-Market Under Nasdaq Rules - Yahoo Finance
60 Degrees Pharmaceuticals to raise $4M via private placement; shares fall - MSN
60 Degrees Pharmaceuticals announces private placement sale - Investing.com India
60 Degrees Pharmaceuticals to sell 2.9M shares at $1.38 in private placement - TipRanks
60 Degrees Pharmaceuticals announces private placement sale By Investing.com - Investing.com Canada
60 Degrees Pharmaceuticals, Inc. Announces $4 Million Private Placement Priced At-the-Market Under Nasdaq Rules - GlobeNewswire
60 Degrees Pharmaceuticals Inc (SXTP)’s Day in Review: Closing at 1.34, Down by -11.84 - The Dwinnex
60 Degrees Pharmaceuticals, Inc. Regains Compliance with Nasdaq Listing Requirements - GlobeNewswire
60 Degrees Pharmaceuticals Inc Share PriceSXTP, RNS News, Articles, Quotes, & Charts (NASDAQ: SXTP) - Proactive Investors Australia
60 Degrees Pharmaceuticals Reports Doubling of Q2 2024 Revenues and Advances Clinical Trials - Proactive Investors Australia
60 Degrees Pharmaceuticals Inc’s Mixed Bag: Down -39.50% in 6 Months, Down -7.00% in 30 Days - The InvestChronicle
Market Resilience: 60 Degrees Pharmaceuticals Inc (SXTP) Finishes Strong at 1.58, Up 1.28 - The Dwinnex
60 Degrees Pharmaceuticals Inc (SXTP)’s stock price range in the last year - US Post News
Q3 2024 EPS Estimates for 60 Degrees Pharmaceuticals, Inc. Boosted by Analyst (NASDAQ:SXTP) - Defense World
60 Degrees Pharmaceuticals Second Quarter 2024 Earnings: Misses Expectations - Yahoo Finance
60 Degrees Pharmaceuticals (NASDAQ:SXTP) Stock Rating Reaffirmed by HC Wainwright - Defense World
60 Degrees Pharmaceuticals (NASDAQ:SXTP) Issues Quarterly Earnings Results - Defense World
Financial Contrast: 60 Degrees Pharmaceuticals (NASDAQ:SXTP) and Antibe Therapeutics (OTCMKTS:ATBPF) - Defense World
60 Degrees Pharmaceuticals reports doubled Q2 revenue By Investing.com - Investing.com Australia
60 Degrees Pharmaceuticals Inc Stock (SXTP) Financials Data
Revenue
Net Income
Cash Flow
EPS
60 Degrees Pharmaceuticals Inc Stock (SXTP) Insider Trading
Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
---|---|---|---|---|---|---|---|
XU CHERYL | Director |
May 16 '24 |
Option Exercise |
0.22 |
2,000 |
446 |
228,934 |
FIELD PAUL | Director |
May 16 '24 |
Option Exercise |
0.22 |
4,000 |
892 |
14,000 |
DOW GEOFFREY S | President and CEO |
Apr 12 '24 |
Option Exercise |
0.27 |
68,000 |
18,142 |
745,625 |
DOW GEOFFREY S | President and CEO |
May 16 '24 |
Option Exercise |
0.22 |
17,000 |
3,791 |
762,625 |
Allen Charles W | Director |
May 16 '24 |
Option Exercise |
0.22 |
4,000 |
892 |
14,000 |
DOW GEOFFREY S | President and CEO |
Jan 31 '24 |
Buy |
0.38 |
25,974 |
9,740 |
703,599 |
XU CHERYL | Director |
Jan 31 '24 |
Buy |
0.38 |
200,000 |
75,000 |
424,934 |
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):